Atıf İçin Kopyala
Demir A., Cecen K., Karadag M. A. , KOCAASLAN R., Turkeri L.
SPRINGERPLUS, cilt.3, 2014 (SCI İndekslerine Giren Dergi)
The first-line management of metastatic prostate cancer is hormonal therapy. However, resistance to this treatment will emerge within an average of 24 months. Our purpose was to determine the course of metastatic prostate cancer under treatment.